248 related articles for article (PubMed ID: 33914484)
21. Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
Kim J; Choi MS; Park J; Park H; Jang HW; Choe JH; Kim JH; Kim JS; Cho YS; Choi JY; Kim TH; Chung JH; Kim SW
Thyroid; 2021 Aug; 31(8):1264-1271. PubMed ID: 33947272
[No Abstract] [Full Text] [Related]
22. Surgical treatment of Graves' disease: evidence-based approach.
Stålberg P; Svensson A; Hessman O; Akerström G; Hellman P
World J Surg; 2008 Jul; 32(7):1269-77. PubMed ID: 18327526
[TBL] [Abstract][Full Text] [Related]
23. Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves' disease.
Cohen RZ; Felner EI; Heiss KF; Wyly JB; Muir AB
J Pediatr Endocrinol Metab; 2016 Mar; 29(3):319-25. PubMed ID: 26656610
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular Health by Graves' Disease Management Modality - Surgery Versus Radioactive Iodine Versus Antithyroid Medications: A Network Meta-Analysis.
Issa PP; Hussein M; Omar M; Munshi R; Attia AS; Buti Y; Aboueisha M; Shama M; Toraih E; Kandil E
J Surg Res; 2023 Mar; 283():266-273. PubMed ID: 36423475
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study.
Fung MHM; Lang BHH
Eur Radiol; 2023 Sep; 33(9):6534-6544. PubMed ID: 37036479
[TBL] [Abstract][Full Text] [Related]
26. Cancer Risk in Graves Disease with Radioactive
Kim KJ; Choi J; Kim KJ; Song E; Yu JH; Kim NH; Yoo HJ; Seo JA; Kim NH; Choi KM; Baik SH; Kim SG
J Nucl Med; 2024 May; 65(5):693-699. PubMed ID: 38548348
[TBL] [Abstract][Full Text] [Related]
27. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
[TBL] [Abstract][Full Text] [Related]
28. The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
Kim YA; Cho SW; Choi HS; Moon S; Moon JH; Kim KW; Park DJ; Yi KH; Park YJ; Cho BY
Thyroid; 2017 Apr; 27(4):491-496. PubMed ID: 28001121
[TBL] [Abstract][Full Text] [Related]
29. Management of Graves' hyperthyroidism: present and future.
Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or Thyroidectomy.
Ryödi E; Metso S; Huhtala H; Välimäki M; Auvinen A; Jaatinen P
Thyroid; 2018 Sep; 28(9):1111-1120. PubMed ID: 29882483
[TBL] [Abstract][Full Text] [Related]
31. The management of pediatric Graves' disease.
Quintanilla-Dieck L
Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):419-423. PubMed ID: 37820281
[TBL] [Abstract][Full Text] [Related]
32. Lower incidence of postpartum thyrotoxicosis in women with Graves disease treated by radioiodine therapy than by subtotal thyroidectomy or with antithyroid drugs.
Yoshihara A; Noh JY; Watanabe N; Iwaku K; Kobayashi S; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Mukasa K; Ito K
Clin Nucl Med; 2014 Apr; 39(4):326-9. PubMed ID: 24566408
[TBL] [Abstract][Full Text] [Related]
33. The tale of radioiodine and Graves' orbitopathy.
Ponto KA; Zang S; Kahaly GJ
Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
[TBL] [Abstract][Full Text] [Related]
34. Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves' Disease.
Kim MJ; Cho SW; Kim YA; Choi HS; Park YJ; Park DJ; Cho BY
Endocrinol Metab (Seoul); 2022 Jun; 37(3):524-532. PubMed ID: 35709827
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of hyperthyroidism diagnosed in childhood and adolescence: a single-centre experience.
Gill DS; Greening JE; Howlett TA; Levy MJ; Shenoy SD
J Pediatr Endocrinol Metab; 2019 Feb; 32(2):151-157. PubMed ID: 30685744
[TBL] [Abstract][Full Text] [Related]
36. "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.
Vigone MC; Peroni E; Di Frenna M; Mora S; Barera G; Weber G
J Endocrinol Invest; 2020 May; 43(5):595-600. PubMed ID: 31713721
[TBL] [Abstract][Full Text] [Related]
37. Is subtotal thyroidectomy a cost-effective treatment for Graves disease? A cost-effectiveness analysis of the medical and surgical treatment options.
Zanocco K; Heller M; Elaraj D; Sturgeon C
Surgery; 2012 Aug; 152(2):164-72. PubMed ID: 22503512
[TBL] [Abstract][Full Text] [Related]
38. The management of Graves' disease in New Zealand 2014.
Cox SC; Tamatea JA; Conaglen JV; Elston MS
N Z Med J; 2016 Jun; 129(1436):10-24. PubMed ID: 27355225
[TBL] [Abstract][Full Text] [Related]
39. Audit of long-term treatment outcomes of thyrotoxicosis in a single-centre virtual clinic: The utility of long-term antithyroid drugs.
Levy MJ; Reddy N; Price D; Bhake R; Bremner E; Barrowcliffe M; Kieffer V; Robinson C; Zaccardi F; Howlett TA
Clin Endocrinol (Oxf); 2022 Nov; 97(5):643-653. PubMed ID: 35274339
[TBL] [Abstract][Full Text] [Related]
40. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
